IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis
BIT:IVG - Borsa Italiana Milan - NL0015000LU4 - Common Stock - Currency: EUR
We assign a fundamental rating of 5 out of 10 to IVG. IVG was compared to 107 industry peers in the Machinery industry. IVG has only an average score on both its financial health and profitability. IVG is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year IVG was profitable.
IVG had a positive operating cash flow in the past year.
IVG had positive earnings in 4 of the past 5 years.
IVG had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
IVG has a Return On Assets of 1.30%. This is in the lower half of the industry: IVG underperforms 60.40% of its industry peers.
With a decent Return On Equity value of 9.60%, IVG is doing good in the industry, outperforming 65.35% of the companies in the same industry.
IVG's Return On Invested Capital of 4.55% is in line compared to the rest of the industry. IVG outperforms 42.57% of its industry peers.
IVG had an Average Return On Invested Capital over the past 3 years of 2.65%. This is significantly below the industry average of 8.38%.
The 3 year average ROIC (2.65%) for IVG is below the current ROIC(4.55%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.3% | ||
| ROE | 9.6% | ||
| ROIC | 4.55% |
ROA(3y)0.81%
ROA(5y)0.07%
ROE(3y)5.93%
ROE(5y)0.58%
ROIC(3y)2.65%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of IVG (1.50%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of IVG has remained more or less at the same level.
Looking at the Operating Margin, with a value of 6.00%, IVG is in line with its industry, outperforming 52.48% of the companies in the same industry.
IVG's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 17.35%, IVG is not doing good in the industry: 89.11% of the companies in the same industry are doing better.
IVG's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6% | ||
| PM (TTM) | 1.5% | ||
| GM | 17.35% |
OM growth 3YN/A
OM growth 5Y3.09%
PM growth 3YN/A
PM growth 5Y-0.56%
GM growth 3Y21.99%
GM growth 5Y1.89%
2. Health
2.1 Basic Checks
IVG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for IVG has been reduced compared to 1 year ago.
The number of shares outstanding for IVG has been increased compared to 5 years ago.
IVG has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 1.82 indicates that IVG is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.82, IVG perfoms like the industry average, outperforming 46.53% of the companies in the same industry.
IVG has a debt to FCF ratio of 18.74. This is a negative value and a sign of low solvency as IVG would need 18.74 years to pay back of all of its debts.
IVG has a Debt to FCF ratio of 18.74. This is in the lower half of the industry: IVG underperforms 62.38% of its industry peers.
A Debt/Equity ratio of 1.52 is on the high side and indicates that IVG has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.52, IVG is doing worse than 87.13% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.52 | ||
| Debt/FCF | 18.74 | ||
| Altman-Z | 1.82 |
ROIC/WACC0.84
WACC5.42%
2.3 Liquidity
IVG has a Current Ratio of 2.12. This indicates that IVG is financially healthy and has no problem in meeting its short term obligations.
IVG has a Current ratio of 2.12. This is in the better half of the industry: IVG outperforms 75.25% of its industry peers.
A Quick Ratio of 1.47 indicates that IVG should not have too much problems paying its short term obligations.
IVG's Quick ratio of 1.47 is amongst the best of the industry. IVG outperforms 80.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.47 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 43.44% over the past year.
The Earnings Per Share has been growing slightly by 5.77% on average over the past years.
The Revenue has decreased by -0.92% in the past year.
IVG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.19% yearly.
EPS 1Y (TTM)43.44%
EPS 3YN/A
EPS 5Y5.77%
EPS Q2Q%21.88%
Revenue 1Y (TTM)-0.92%
Revenue growth 3Y15.91%
Revenue growth 5Y6.19%
Sales Q2Q%-8.28%
3.2 Future
The Earnings Per Share is expected to grow by 25.48% on average over the next years. This is a very strong growth
IVG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.06% yearly.
EPS Next Y68.53%
EPS Next 2Y36.36%
EPS Next 3Y31.43%
EPS Next 5Y25.48%
Revenue Next Year-4.85%
Revenue Next 2Y-2%
Revenue Next 3Y0.74%
Revenue Next 5Y4.06%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 6.51, the valuation of IVG can be described as very cheap.
IVG's Price/Earnings ratio is rather cheap when compared to the industry. IVG is cheaper than 92.08% of the companies in the same industry.
IVG's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.47.
The Price/Forward Earnings ratio is 5.83, which indicates a rather cheap valuation of IVG.
96.04% of the companies in the same industry are more expensive than IVG, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 92.74, IVG is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.51 | ||
| Fwd PE | 5.83 |
4.2 Price Multiples
IVG's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IVG is cheaper than 86.14% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, IVG is valued a bit cheaper than 72.28% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.16 | ||
| EV/EBITDA | 4.08 |
4.3 Compensation for Growth
IVG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as IVG's earnings are expected to grow with 31.43% in the coming years.
PEG (NY)0.09
PEG (5Y)1.13
EPS Next 2Y36.36%
EPS Next 3Y31.43%
5. Dividend
5.1 Amount
IVG has a Yearly Dividend Yield of 1.84%.
Compared to an average industry Dividend Yield of 3.14, IVG pays a bit more dividend than its industry peers.
IVG's Dividend Yield is comparable with the S&P500 average which is at 2.28.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.84% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
38.89% of the earnings are spent on dividend by IVG. This is a low number and sustainable payout ratio.
DP38.89%
EPS Next 2Y36.36%
EPS Next 3Y31.43%
IVECO GROUP NV
BIT:IVG (2/5/2025, 5:35:15 PM)
11.39
-0.26 (-2.27%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners42.58%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.09B
Analysts76
Price Target13.28 (16.59%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.84% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP38.89%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.3%
Min EPS beat(2)7.26%
Max EPS beat(2)47.35%
EPS beat(4)3
Avg EPS beat(4)27.55%
Min EPS beat(4)-67.17%
Max EPS beat(4)122.78%
EPS beat(8)5
Avg EPS beat(8)10.19%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.06%
Min Revenue beat(2)0.94%
Max Revenue beat(2)1.19%
Revenue beat(4)3
Avg Revenue beat(4)1.24%
Min Revenue beat(4)-6.08%
Max Revenue beat(4)8.93%
Revenue beat(8)4
Avg Revenue beat(8)1.29%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.69%
PT rev (3m)-6.4%
EPS NQ rev (1m)-12.34%
EPS NQ rev (3m)52.69%
EPS NY rev (1m)4.83%
EPS NY rev (3m)4.83%
Revenue NQ rev (1m)8.04%
Revenue NQ rev (3m)-8%
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)-0.26%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.51 | ||
| Fwd PE | 5.83 | ||
| P/S | 0.2 | ||
| P/FCF | 10.16 | ||
| P/OCF | 2.44 | ||
| P/B | 1.27 | ||
| P/tB | 5.8 | ||
| EV/EBITDA | 4.08 |
EPS(TTM)1.75
EY15.36%
EPS(NY)1.95
Fwd EY17.14%
FCF(TTM)1.12
FCFY9.84%
OCF(TTM)4.67
OCFY41.01%
SpS57.55
BVpS8.99
TBVpS1.97
PEG (NY)0.09
PEG (5Y)1.13
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.3% | ||
| ROE | 9.6% | ||
| ROCE | 7.51% | ||
| ROIC | 4.55% | ||
| ROICexc | 5.6% | ||
| ROICexgc | 6.9% | ||
| OM | 6% | ||
| PM (TTM) | 1.5% | ||
| GM | 17.35% | ||
| FCFM | 1.95% |
ROA(3y)0.81%
ROA(5y)0.07%
ROE(3y)5.93%
ROE(5y)0.58%
ROIC(3y)2.65%
ROIC(5y)N/A
ROICexc(3y)3.13%
ROICexc(5y)N/A
ROICexgc(3y)3.69%
ROICexgc(5y)N/A
ROCE(3y)4.36%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y0.26%
ROICexc growth 3YN/A
ROICexc growth 5Y0.64%
OM growth 3YN/A
OM growth 5Y3.09%
PM growth 3YN/A
PM growth 5Y-0.56%
GM growth 3Y21.99%
GM growth 5Y1.89%
F-Score6
Asset Turnover0.87
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.52 | ||
| Debt/FCF | 18.74 | ||
| Debt/EBITDA | 2.34 | ||
| Cap/Depr | 149.07% | ||
| Cap/Sales | 6.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 80.04% | ||
| Profit Quality | 129.92% | ||
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.47 | ||
| Altman-Z | 1.82 |
F-Score6
WACC5.42%
ROIC/WACC0.84
Cap/Depr(3y)133.39%
Cap/Depr(5y)112.05%
Cap/Sales(3y)5.28%
Cap/Sales(5y)4.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.44%
EPS 3YN/A
EPS 5Y5.77%
EPS Q2Q%21.88%
EPS Next Y68.53%
EPS Next 2Y36.36%
EPS Next 3Y31.43%
EPS Next 5Y25.48%
Revenue 1Y (TTM)-0.92%
Revenue growth 3Y15.91%
Revenue growth 5Y6.19%
Sales Q2Q%-8.28%
Revenue Next Year-4.85%
Revenue Next 2Y-2%
Revenue Next 3Y0.74%
Revenue Next 5Y4.06%
EBIT growth 1Y6.96%
EBIT growth 3YN/A
EBIT growth 5Y9.47%
EBIT Next Year68.36%
EBIT Next 3Y27.99%
EBIT Next 5Y20.71%
FCF growth 1Y623.81%
FCF growth 3Y32.31%
FCF growth 5YN/A
OCF growth 1Y71.91%
OCF growth 3Y33.7%
OCF growth 5Y30.35%